EndoAnchors预防与治疗EVAR近端封闭失败的中期单中心经验
单中心回顾性分析92例连续接受Heli-FX EndoAnchors(EA)治疗的患者,分为初次EVAR预防组(PA,73例,85%为不良瘤颈)与近端固定失败翻修组(RA,19例,90%联合肾下延伸袖套)。中位随访4.1年,PA组5年免于1a型内漏和/或支架移植物移位为87.3%,RA组为58.8%,提示EA在初次EVAR中收益更高。
要点
- 初次EVAR中应用EA于不良瘤颈可获得较高的中期免于T1aEL和/或移位率。
- 以EA翻修近端失败获益有限,5年免于T1aEL和/或移位仅58.8%。
- 复杂近端失败病例可考虑开窗EVAR或开放手术。
核心结论
- 在不良瘤颈解剖的初次EVAR中使用EndoAnchors可获得较高的中期免于T1aEL和/或支架移植物移位率。
- 以EndoAnchors治疗主动脉支架近端失败获益较少,此类复杂病例开窗EVAR或开放修复可能更合适。
研究设计与样本
- 单中心回顾性分析2010年6月至2018年3月连续92例接受EndoAnchors治疗的患者。
- EA于初次EVAR(PA,73例)或近端固定失败翻修(RA,19例)中置入,RA中90%联合肾下延伸袖套。
- 主要终点为免于1a型内漏(T1aEL)和/或支架移植物移位;次要终点为免于近端再干预生存与总生存。
- 92例患者中位随访4.1年(四分位距2.0-6.4年)。
主要发现
- PA组85%具有不良肾下瘤颈形态。
- 术后首次(<60天)影像无T1aEL的治疗成功率PA组为97%,RA组为74%。
- 5年免于T1aEL和/或支架移植物移位PA组为87.3%,RA组为58.8%。
- 5年总生存PA组为65.1%,RA组为51.4%;5年免于近端再干预PA组为89.3%,RA组为79.7%。
临床怎么用
- 对不良瘤颈行初次EVAR时可考虑置入EndoAnchors以提高耐久性并减少二次干预。
- 处理EVAR后近端失败时应谨慎评估,EA获益有限,可考虑开窗EVAR或开放修复。
- 术后早期(<60天)影像评估T1aEL可用于判断治疗成功与否。
局限性
- 为单中心回顾性系列,样本量有限(92例)。
- PA与RA为非随机分组,两组基线及处理方式存在差异(RA中90%联合延伸袖套)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundThis study assesses the efficacy of Heli-FX EndoAnchors (EA) in the prevention and treatment of proximal failures after endovascular aortic aneurysm repair (EVAR).MethodsOutcomes of 92 consecutive patients treated with EAs, between June 2010 and March 2018, were retrospectively analyzed. The EAs were deployed during primary EVAR (primary arm [PA]) or revisions for failing proximal fixation (revision arm [RA]). The primary endpoint was freedom from type 1a endoleak (T1aEL) and/or stent-graft migration; secondary end points were proximal reintervention-free survival and overall survival.ResultsThe median follow-up among the 92 patients was 4.1 years (interquartile range=2.0-6.4). The PA consisted of 73 patients, of which 85% had hostile infrarenal neck morphology. In the RA, 19 patients received EAs, combined with an infrarenal extension cuff in 90% of cases. Treatment success, defined as absence of T1aEL on the first (<60 days) post-operative imaging studies, was 97% in the PA and 74% in the RA, respectively. Five-year freedom from T1aEL and/or stent-graft migration was 87.3% in the PA and 58.8% in the RA. Overall survival at 5 years was 65.1% and 51.4% in the PA and RA, respectively, and freedom from proximal reintervention was 89.3% in the PA and 79.7% in the RA.ConclusionsIn this single-center retrospective series, EndoAnchors used during primary EVAR in hostile neck anatomy demonstrated high mid-term freedom from T1aEL and/or stent-graft migration. The use of EAs to treat proximal failure of aortic endografts showed less benefit. In these complex cases, fenestrated EVAR or open repair may be more appropriate.Clinical ImpactThis study demonstrates that the use of EndoAnchors during primary endovascular aortic aneurysm repair (EVAR) is associated with high mid-term freedom from type 1a endoleaks and stent-graft migration. These findings suggest that EndoAnchor placement may improve EVAR durability, particularly in patients with hostile neck anatomy, and reduce the need for secondary interventions in this high-risk group. In contrast, the more limited benefit observed in revision settings highlights the need to carefully consider alternative treatment strategies when treating proximal failure after EVAR.
引用
- Mesman JL, van Veldhuizen WA, W van Lammeren G, et al. EndoAnchors for Prevention and Treatment of Proximal Seal Failure in EVAR: A Mid-term Single-Center Experience. J Endovasc Ther. 2026. PMID: 41978479. doi:10.1177/15266028261434173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。